Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells

M. Jelinek, A. Kabelova, J. Sramek, J. Seitz, I. Ojima, J. Kovar,

. 2017 ; 37 (4) : 1581-1590.

Language English Country Greece

Document type Journal Article

BACKGROUND/AIM: Classical taxanes are routinely used in cancer therapy. In this study, mechanisms involved in death induction by the novel fluorine-containing taxane SB-T-12854 were investigated. MATERIALS AND METHODS: We employed breast cancer SK-BR-3, MCF-7 and T47D cell lines to assess activation of individual caspases, changes in the expression of proteins of the Bcl-2 family, and the release of pro-apoptotic factors from mitochondria into the cytosol after SB-T-12854 treatment. RESULTS: Caspase-2, -8, and -9 were activated in SK-BR-3 and MCF-7 cells. Only caspase-8 was activated in T47D cells. Caspase-7 and -6 were activated in all tested cells while caspase-3 was activated only in SK-BR-3 cells. Pro-apoptotic Bad protein seems to be important for cell death induction in all tested cells. Anti-apoptotic Bcl-2 and pro-apoptotic Bim, Bok, Bid and Bik seem to be also associated with cell death induction in some of the tested cells. The mitochondrial apoptotic pathway was significantly activated in association with the release of cytochrome c and Smac from mitochondria, but only in SK-BR-3 cells, not in MCF-7 and T47D cells. CONCLUSION: Cell death induced by SB-T-12854, in the tested breast cancer cells, differs regarding activation of caspases, changes in levels of pro-apoptotic and anti-apoptotic proteins of the Bcl-2 family and activation of the mitochondrial apoptotic pathway.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023163
003      
CZ-PrNML
005      
20170828130937.0
007      
ta
008      
170720s2017 gr f 000 0|eng||
009      
AR
024    7_
$a 10.21873/anticanres.11488 $2 doi
035    __
$a (PubMed)28373418
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Jelinek, Michael $u Department of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
245    10
$a Differing Mechanisms of Death Induction by Fluorinated Taxane SB-T-12854 in Breast Cancer Cells / $c M. Jelinek, A. Kabelova, J. Sramek, J. Seitz, I. Ojima, J. Kovar,
520    9_
$a BACKGROUND/AIM: Classical taxanes are routinely used in cancer therapy. In this study, mechanisms involved in death induction by the novel fluorine-containing taxane SB-T-12854 were investigated. MATERIALS AND METHODS: We employed breast cancer SK-BR-3, MCF-7 and T47D cell lines to assess activation of individual caspases, changes in the expression of proteins of the Bcl-2 family, and the release of pro-apoptotic factors from mitochondria into the cytosol after SB-T-12854 treatment. RESULTS: Caspase-2, -8, and -9 were activated in SK-BR-3 and MCF-7 cells. Only caspase-8 was activated in T47D cells. Caspase-7 and -6 were activated in all tested cells while caspase-3 was activated only in SK-BR-3 cells. Pro-apoptotic Bad protein seems to be important for cell death induction in all tested cells. Anti-apoptotic Bcl-2 and pro-apoptotic Bim, Bok, Bid and Bik seem to be also associated with cell death induction in some of the tested cells. The mitochondrial apoptotic pathway was significantly activated in association with the release of cytochrome c and Smac from mitochondria, but only in SK-BR-3 cells, not in MCF-7 and T47D cells. CONCLUSION: Cell death induced by SB-T-12854, in the tested breast cancer cells, differs regarding activation of caspases, changes in levels of pro-apoptotic and anti-apoptotic proteins of the Bcl-2 family and activation of the mitochondrial apoptotic pathway.
650    _2
$a apoptóza $x účinky léků $7 D017209
650    _2
$a nádorové biomarkery $x metabolismus $7 D014408
650    _2
$a western blotting $7 D015153
650    _2
$a nádory prsu $x farmakoterapie $x patologie $7 D001943
650    _2
$a kaspasy $x metabolismus $7 D020169
650    _2
$a proliferace buněk $x účinky léků $7 D049109
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a fluorované uhlovodíky $x farmakologie $7 D006845
650    _2
$a taxoidy $x farmakologie $7 D043823
650    _2
$a nádorové buňky kultivované $7 D014407
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kabelova, Adela $u Department of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Sramek, Jan $u Department of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Seitz, Joshua $u Institute of Chemical Biology and Drug Discovery, State University of New York at Stony Brook, Stony Brook, NY, U.S.A.
700    1_
$a Ojima, Iwao $u Institute of Chemical Biology and Drug Discovery, State University of New York at Stony Brook, Stony Brook, NY, U.S.A.
700    1_
$a Kovar, Jan $u Department of Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic jan.kovar@lf3.cuni.cz.
773    0_
$w MED00000478 $t Anticancer research $x 1791-7530 $g Roč. 37, č. 4 (2017), s. 1581-1590
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28373418 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170828131523 $b ABA008
999    __
$a ok $b bmc $g 1238844 $s 984076
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 37 $c 4 $d 1581-1590 $i 1791-7530 $m Anticancer research $n Anticancer Res $x MED00000478
LZP    __
$a Pubmed-20170720

Find record

Citation metrics

Logged in users only

Archiving options

Loading data ...